Sen. John Hoeven sold THE CAMPBELL FUND TRUST - SERIES A Company: THE CAMPBELL FUND TRUST - SERIES A (BALTIMORE, MARYLAND) Description: INVETMENT MANAGEMENT IN FUTURES AND CASH EQUITY STRATEGIES

Sen. John Hoeven (R-ND) · $50K–$100K · traded Jan 12, 2017

Transaction: Sold (full)
Amount: $50K–$100K
Owner: The member
Traded: Jan 12, 2017
Disclosed: Jan 25, 2017
Days to disclose: 13
Asset type: Other
As filed: THE CAMPBELL FUND TRUST - SERIES A Company: THE CAMPBELL FUND TRUST - SERIES A (BALTIMORE, MARYLAND) Description: INVETMENT MANAGEMENT IN FUTURES AND CASH EQUITY STRATEGIES

Other trades in this filing

DisclosedTradeAmount

Jan 25, 2017
Sold (full) Merck & Co. MRK
$50K–$100K · Traded Jan 25, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Willis Towers Watson Public Limited Company WTW
$50K–$100K · Traded Jan 24, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought V.F. VFC
$50K–$100K · Traded Jan 23, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Cisco Systems CSCO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought Verizon Communications VZ
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) Johnson & Johnson JNJ
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Pfizer PFE
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Intel INTC
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought The Procter & Gamble Company PG
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought The Coca-Cola Company KO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Bristol-Myers Squibb Company BMY
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought PepsiCo PEP
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Amgen AMGN
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) AbbVie ABBV
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought AT&T T
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.